CLINICAL_TRIALS
research
· 2015-04-17
Clinical Trial Update: Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia [NA]
Summary
A clinical trial update examining how COMT genotype affects response to cognitive remediation in individuals with chronic schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Manhattan Psychiatric Center | Conditions: Chronic Schizophrenia | NA | Status: UNKNOWN